EUVIMEDEUVIMED entdecken
Crossref

Cardiac Autoantibodies Against Cardiac Troponin I in Post-Myocardial Infarction Heart Failure: Evaluation in a Novel Murine Model and Applications in Therapeutics

Shun Furusawa, Masataka Ikeda iD, Tomomi Ide iD, Takuya Kanamura, Hiroko Deguchi Miyamoto iD, Ko Abe iD, Kosei Ishimaru, Masatsugu Watanabe, Yoshitomo Tsutsui, Ryo Miyake, Satoshi Fujita, Takeshi Tohyama iD und 3 weitere

Circulation: Heart Failure · 2023

DOI: 10.1161/circheartfailure.122.010347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Heart Failure, 2023. Verfasst von Shun Furusawa und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine (S. Furusawa, M.I., T.I., T.K., H.D.M., K.A., K.I., M.W., Y.T., R.M., S. Fujita, T.T., S.M., H.T.), Faculty of …. Hauptthemen laut MEDLINE: Heart Failure, Myocardial Infarction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cardiac autoantibodies (cAAbs) are involved in the progression of adverse cardiac remodeling in heart failure (HF). However, our understanding of cAAbs in HF is limited owing to the absence of relevant animal models. Herein, we aimed to establish and characterize a murine model of cAAb-positive HF after myocardial infarction (MI), thereby facilitating the development of therapeutics targeting cAAbs in post-MI HF. METHODS: MI was induced in BALB/c mice. Plasma cAAbs were evaluated using modified Western blot-based methods. Prognosis, cardiac function, inflammation, and fibrosis were compared between cAAb-positive and cAAb-negative MI mice. Rapamycin was used to inhibit cAAb production. RESULTS: Common cAAbs in BALB/c MI mice targeted cTnI (cardiac troponin I). Herein, 71% (24/34) and 44% (12/27) of the male and female MI mice, respectively, were positive for cAAbs against cTnI (cTnIAAb). Germinal centers were formed in the spleens and mediastinal lymph nodes of cTnIAAb-positive MI mice. cTnIAAb-positive MI mice showed progressive cardiac remodeling with a worse prognosis ( P =0.014, by log-rank test), which was accompanied by cardiac inflammation, compared with that in cTnIAAb-negative MI mice. Rapamycin treatment during the first 7 days after MI suppressed cTnIAAb production (cTnIAAb positivity, 59% [29/49] and 7% [2/28] in MI mice treated with vehicle and rapamycin, respectively; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMyocardial InfarctionMiceMaleFemaleAnimalsMyocardiumTroponin IDisease Models, AnimalAutoantibodiesVentricular RemodelingInflammationSirolimus

Stichwörter der Autor:innen

autoantibodiesheart failureinflammationmyocardial infarctiontroponin I

Substanzen

Troponin IAutoantibodiesSirolimus

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine (S. Furusawa, M.I., T.I., T.K., H.D.M., K.A., K.I., M.W., Y.T., R.M., S. Fujita, T.T., S.M., H.T.), Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Division of Cardiovascular Medicine, Research Institute of Angiocardiology (S. Furusawa, M.I., T.I., T.K., H.D.M., K.A., K.I., M.W., Y.T., R.M., S. Fujita, S.M., H.T.), Faculty of Medical Sciences, Kyushu University, Fu…
  • Department of Anesthesiology and Critical Care Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan (M.W.).
  • Center for Clinical and Translational Research of Kyushu University Hospital, Fukuoka, Japan (T.T.).
  • Department of Molecular Genetics, Division of Immunology and Genome Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan (Y.B.).
  • School of Medicine and Graduate School, International University of Health and Welfare, Fukuoka, Japan (H.T.).

ORCID-Profile: Masataka Ikeda, Tomomi Ide, Hiroko Deguchi Miyamoto, Ko Abe, Takeshi Tohyama, Shouji Matsushima

Zitieren

APA

Furusawa, S., Ikeda, M., Ide, T., Kanamura, T., Miyamoto, H. D., Abe, K., Ishimaru, K., Watanabe, M., Tsutsui, Y., Miyake, R., Fujita, S., Tohyama, T., Matsushima, S., Baba, Y., & Tsutsui, H. (2023). Cardiac Autoantibodies Against Cardiac Troponin I in Post-Myocardial Infarction Heart Failure: Evaluation in a Novel Murine Model and Applications in Therapeutics. Circulation: Heart Failure. https://doi.org/10.1161/circheartfailure.122.010347

Vancouver

Furusawa S, Ikeda M, Ide T, Kanamura T, Miyamoto HD, Abe K, et al. Cardiac Autoantibodies Against Cardiac Troponin I in Post-Myocardial Infarction Heart Failure: Evaluation in a Novel Murine Model and Applications in Therapeutics. Circulation: Heart Failure. 2023. doi:10.1161/circheartfailure.122.010347

BibTeX
@article{Furusawa2023,
  author = {Furusawa, Shun and Ikeda, Masataka and Ide, Tomomi and Kanamura, Takuya and Miyamoto, Hiroko Deguchi and Abe, Ko and Ishimaru, Kosei and Watanabe, Masatsugu and Tsutsui, Yoshitomo and Miyake, Ryo and Fujita, Satoshi and Tohyama, Takeshi and Matsushima, Shouji and Baba, Yoshihiro and Tsutsui, Hiroyuki},
  title = {Cardiac Autoantibodies Against Cardiac Troponin I in Post-Myocardial Infarction Heart Failure: Evaluation in a Novel Murine Model and Applications in Therapeutics},
  journal = {Circulation: Heart Failure},
  year = {2023},
  doi = {10.1161/circheartfailure.122.010347}
}
Kostenlos starten →